INTRODUCTION
Gastric carcinoma is the second leading cause of cancer deaths worldwide, however, its incidence varies greatly between Eastern and Western countries. [1] The most important prognostic factors in gastric cancer (GC) include depth of invasion, lymph node (LN) involvement, and distant metastases. [2, 3] Preoperative knowledge of LN status is helpful for clinical staging and for planning the optimal treatment. The Japanese Research Society for the Study of Gastric Cancer (JRSGC) has described 16 nodal stations, which surround the stomach, and depending upon the location of the primary tumor; they are grouped into N1, N2, and N3 groups [Figures 1a and b] . [4] In general station N1 LNs are perigastric in location, N2 LNs lie around celiac artery (CAL) and its branches and N3 LNs are found in the ligaments surrounding stomach and in retroperitoneum. [5] Most investigators have found, high sensitivity (60-90%) and relatively low specificity of multidetector spiral computed tomography (MDCT) for nodal staging. [6, 7] The accuracy of magnetic resonance imaging is considered to be inferior to MDCT for N staging. [8] Staging accuracy, and decision-making, is improved when positron emission tomography (PET) and CT are both utilized rather than either alone. [9] Currently, endoscopic ultrasonography (EUS) is accepted as the most effi cient diagnostic method for T staging and has been found efficient for N staging also. [10] [11] [12] Comparative study of EUS and multislice spiral CT in GC has shown greater accuracy of EUS for N staging. [13] The most recent guidelines of the National Comprehensive Cancer Network introduced EUS as a preferred modality of GC staging if no evidence of M1 disease is present at CT-PET. [14] EUS guided fi ne-needle aspiration (FNA) cytology of LN stations defined by international association of study of lung cancer has made a signifi cant impact in the management of lung cancer. [15] [16] [17] [18] The use of EUS in the preoperative determination of LN status in patients with GC can have a signifi cant impact on patient management. [19] EUS elastography signifi cantly improves the specifi city of LN staging in esophageal cancer and can be useful in GC also. [12, 20] A technique for identifi cation of individual LN stations suggested by JRSGC has not been described so far by EUS. This article presents a technique to identify the regional nodal stations of GC by EUS.
PROCEDURE
Two scanning methods are used for EUS examination of the stomach and duodenum: The water-filling method (by introducing 300-500 ml of 0.9% isotonic saline solution into the stomach) and the balloon contact method. A systematic examination of retroperitoneal organs and the vessels is required. Retroperitoneal organs (kidney, spleen, pancreas and adrenal gland) are identified by their characteristic appearance. The examination of vessels of portal venous system, aorta and its branches and the inferior vena cava and its tributaries is done by conventional techniques. [21, 22] During imaging of LN stations additional efforts are made to follow the course of vessels as far as possible with the help of color Doppler. This helps in tracing the course of vessels in the ligaments surrounding the stomach and duodenum where the N2 and N3 LNs are located. On EUS, the ligaments of stomach can be identifi ed as hyperechoic areas between two adjacent organs on the lesser curvature (hepatogastric and hepatoduodenal ligament-lesser omentum) [23] and greater curvature (gastrophrenic, gastrosplenic, lienorenal and gastrocolic ligament-greater omentum). The LNs are identified by their characteristic appearance. The scanning is done in a systematic way to identify each LN station [Figures 1a and b, Video 1 and table] . [4] The imaging of peri-gastric LNs (N1 stations 1-6) is done from esophagogastric junction and fundus for stations 1 and 2, from body of the stomach for stations 3 and 4 and from the antrum and the first part of the duodenum for stations 5 and 6 [ Figures 2-11 
DISCUSSION
The nomenclature of nodal stations in abdomen is based primarily on the relationship of the lymphatic drainage (LNs) that follows the accompanying vessel (artery and vein) or a direct relationship with the regional organ. The accompanying vessels traverse through the ligaments surrounding stomach and the metastatic nodes commonly reside in ligaments rather than the retroperitoneum. [24] Soon after the first descriptions of the five-layer structure of the gastric wall, [25] EUS became a standard technique for the staging of GC. Until a few years ago, the impact of EUS in GC was limited by the lack of therapeutic options, surgery being the only recourse either with curative or with palliative intent. The clinical arena of GC has changed substantially in recent years as treatments have become more numerous. Besides the traditional surgical approach, endoscopic mucosal resection and submucosal dissection are adopted Figure 5b . In this image, the left gastric vein is seen joining the upper part of the portal vein (PV) and this lymph node (LN) lies very close to the upper part of the lesser curvature. The left gastric artery and vein run together in the hepatogastric ligament and a LN, which lies close to either, can be included in 3a. The LN labeled as 11p lies more close to the splenic artery than to the lesser curvature and hence is not included in station 3a. An LN lying near the PV (12p) is also seen. The LNs of the 3b (not seen in this image) station lie along the right gastric artery in the lower part of the lesser curvature. The origin and course of right gastric artery is diffi cult to identify on endoscopic ultrasonography.
LGV: Left gastric vein, PV: Portal vein The LN labeled as 8a can be also included in station 3b and such cases the proximity to the vessel or to the wall of the stomach will decide the station. In this case, the station 8a LN is equidistant from HA and from wall of the stomach. HA: Hepatic artery One of the LNs is touching the SA and can be labeled as either 8a or 11p. At this point, the distance between HA and SA is only about 5 mm, and it is not possible to differentiate between 8a and 11p Figure 16 . The lymph node (LN) labeled as station 9 lies just above the celiac artery (CAL) and in front of the abdominal aorta. The CAL takes a course anteriorly after taking origin from the abdominal aorta. This LN is seen just above the anterior most part of CAL. The trunk of left gastric artery near its origin is also seen, but this LN is closest to the CAL and hence is labeled as station 9. Another LN lying below the CAL lies close to the abdominal aorta and belongs to station 16A2. A LN belonging to 11p station lies near the lower border of the splenic artery Figure 17 . The celiac artery (CAL) takes a vertical course anteriorly after taking origin from the abdominal aorta. This lymph node (LN) is seen just above the anterior most part of CAL, which is not seen in this frame. The splenic artery (SA) is the most tortuous artery of the whole body and in this frame is seen lying anterior to aorta. The LN lying above SA is closer to CAL and anterior to aorta and thus belongs to station 9 Imaging from stomach can sometimes push the scope below the level of head and body of pancreas. A lymph node (LN) lying cranial to duodenal papilla during imaging from 2 nd part of the duodenum can be considered as station 13 whereas an LN lying below the papilla will lie close to the lower border of PAN and will belong to station 18 Figure 27 . The superior mesenteric artery (SMA) is the second ventral branch of the aorta, given off slightly below the celiac trunk, which descends in a groove on the posterior surface of the neck of the pancreas. Below the inferior margin of the neck of the PAN, it goes anterior to the uncinate process and the horizontal portion of the duodenum and enters the root of the mesentery. It is easy to identify lymph node (LN) close to SMA and superior mesenteric vein (SMV) from the horizontal portion of the duodenum. In this image, the LN is seen near the root of mesentery close to the origin of SMA and also close to the place where the SMV is about to join splenic vein for formation of the portal vein. The SMA nodes (14a) can lie behind the body of PAN, on the uncinate process of PAN or near the root of mesentery . Within the mesentery, the main arterial stem of superior mesenteric artery (SMA) describes an arc that spans the distance between the horizontal duodenum and the ileocecal junction, where the SMA terminates by anastomosing with one of its own branches, the ileocolic artery. Of the arteries to the large intestine, the middle colic artery (MCA) is the fi rst to arise from the right side of the SMA. This branch is usually given off at the inferior margin of the neck of the pancreas before the SMA enters the mesentery. The MCA passes into the transverse mesocolon. In this image, the jejunal branches are seen going away from the probe, and the inferior pancreaticoduodenal artery is seen as the fi rst branch arising from the right side of the SMA coming toward the probe. The second branch coming from the right side of SMA is MCA, which is seen to enter the transverse mesocolon. MCA: Middle colic artery, INFR PDA: Inferior pancreaticoduodenal artery, IMV: Inferior mesenteric vein Figure 29b . The lymph node (LN) lying along middle colic artery belongs to station 15. In the second image, a LN is also seen along the fi rst-jejunal vein for the early stages of the disease, and neoadjuvant therapies are used for the advanced stages. As a consequence, the potential role of EUS in GC has become much more attractive to identify the patients suitable for minimally invasive treatment, those who should undergo primary surgery, and those who need neoadjuvant therapy. [10] Under-or over-staging of LN disease has been noted when EUS is used alone [26] and a multimodality imaging with CT, PET scan along with EUS and EUS-FNA of nodal stations Imaging from stomach can sometimes push the scope below the level of head and body of pancreas. A lymph node (LN) lying cranial to duodenal papilla can be considered as station 13 whereas a LN lying below the papilla will lie near the lower border of PAN and will belong to station 18. In this case, the papilla is not seen but two LN lies behind the PAN in retroperitoneum and belongs to station 13 and another LN, which belong to station 18 lies along the inferior border of the body of PAN may provide a more detailed staging. The additional value of EUS-FNA over EUS alone for N and M staging of GC are emphasized in a study where distant LN and liver metastases were detected by EUS-FNA in 42% of the patients, and CT of the abdomen or thorax had previously failed to show any abnormality. [27] Although preliminary reports have yielded confl icting results in this respect, GC restaging after neoadjuvant treatment is likely to emerge as another clinical task for endosonographers. [2] The practical impact and use of EUS in treatment decisions in GC patients is lower than would have been expected from the EUS. This may be due to lack of application of EUS for N staging. EUS-FNA should be considered an integral part of the EUS staging procedure for GC in the near future. This review elaborately describes the technique for proper identifi cation of nodal stations by EUS. 
